Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 1, 2013
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patientsPeter T Daley-Yates, Rashmi Mehta, Robert H Chan, et al.Journal of Clinical Pharmacology|June 5, 2014
Dose response of umeclidinium administered once or twice daily in patients with COPD: a pooled analysis of two randomized, double-blind, placebo-controlled studiesJames F Donohue, Christopher Kalberg, Palvi Shah, et al.Pulmonary Pharmacology & Therapeutics|September 8, 2016
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler in patients with asthmaRobert Chan, Ana R Sousa, Stephen Mallett, et al.European Journal of Pharmacology|January 2, 2013
Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: two randomised studiesRuth Tal-Singer, Anthony Cahn, Rashmi Mehta, et al.The Clinical Respiratory Journal|February 15, 2012
Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPDEric Bateman, Gregory Feldman, Sally Kilbride, et al.Journal of Breast Imaging|February 29, 2024
Cancer Conspicuity on Low-energy Images of Contrast-enhanced Mammography Compared With 2D MammographyChristina Konstantopoulos, Tejas S Mehta, Alexander Brook, et al.Clinical Pharmacology and Therapeutics|July 17, 2024
Integrated Population Exposure-Response of Dolutegravir in HIV-1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient CharacteristicsHardik Chandasana, Mark Bush, Cindy Vavro, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 16, 2012
Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patientsJutta Beier, Jan van Noord, Amanda Deans, et al.Pulmonary Pharmacology & Therapeutics|July 19, 2014
Pharmacokinetics of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhalerRashmi Mehta, Peter T Daley-Yates, Kevin Jenkins, et al.Clinical Drug Investigation|June 21, 2013
Safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat inhaled doses of umeclidinium in healthy subjects: two randomized studiesAnthony Cahn, Ruth Tal-Singer, Isabelle J Pouliquen, et al.Pageof 6